Valerie Hoffman

Chief Research Officer

Meru Health

Valerie Hoffman is the Head of Research with Meru Health. She received her MPH from Yale University and doctorate in psychiatric epidemiology from Johns Hopkins University’s Bloomberg School of Public Health. She has over 20 years of experience in designing studies, analyzing findings, and reporting results in over 80 peer-reviewed publications. Dr. Hoffman has been the Principal Investigator of NIH, VA, SAMHSA, AHRQ, DoD, and CDC-funded studies and currently is conducting a randomized controlled trial to test the efficacy of the Meru Health Program.

Speaker Questionnaire

What are your top priorities for employee health and well-being in 2022?

What are the most innovative programs that you will focus on in 2022 and 2023?

Looking at our three moonshots surrounding costs, culture, and care, which do you align with the most? What are you doing in this area?

If you could automatically receive a 25% reduction in costs in three areas/programs, what would your dream list be?

Is there an area where you were able to either create savings or stop costs from rising?

Are you doing anything to reimagine corporate culture and wellbeing?

If there were two physical solutions that could be turned into virtual or remote care instead, what would those be?

If you look at our 3 Moonshots - Costs, Culture, and Care; In one sentence, tell us what would be something positive for us to take from 2020 and bring into this new year?

Sessions Speaking

No items found.

1 Conference. 3 Moonshots.

Remember the mission to reach the moon? In 1962, President JFK set forth a vision. He initiated a movement that outlived him! Even in his death, the mission was accomplished seven years after his famous speech. Now we’re on a five-year mission, and it's not about us. This is a mission for you – the individual, the stakeholder, the employer healthcare and benefits professional. Join the mission to reduce costs, reimagine culture, and reinvent care.